Focus on progressive myoclonic epilepsy in Berardinelli-Seip syndrome

• Published in: Neurological sciences Vol. 41; no. 11; pp. 3345 - 3348
• Main Authors: Ferranti, Silvia, Lo Rizzo, Caterina, Renieri, Alessandra, Galluzzi, Paolo, Grosso, Salvatore
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.11.2020
• Subjects: Adipose Tissue; Adolescent; Brief Communication; Child; GTP-Binding Protein gamma Subunits - genetics; Humans; Lipodystrophy, Congenital Generalized - complications; Lipodystrophy, Congenital Generalized - diagnosis; Lipodystrophy, Congenital Generalized - genetics; Medicine; Medicine & Public Health; Myoclonic Epilepsies, Progressive - genetics; Neurology; Neuroradiology; Neurosurgery; Phenotype; Psychiatry; Progressive Myoclonic Epilepsy; Congenital Generalized Lipodystrophy type 2; Seipin; Berardinelli-Seip syndrome
• ISSN: 1590-1874; 1590-3478
• DOI: 10.1007/s10072-020-04418-1

Introduction Berardinelli-Seip syndrome or congenital generalized lipodystrophy type 2 is a rare genetic disorder characterized by selective loss of subcutaneous adipose tissue associated with peripheral insulin resistance and its complications. Nonprogressive mental retardation, dystonia, ataxia, and pyramidal signs are commonly present, whereas epilepsy has only occasionally been observed. Case report We report the case of two sisters, 11 and 18 years old respectively, with an overlapping clinical phenotype compatible with Berardinelli-Seip syndrome and progressive myoclonic epilepsy. Molecular analysis identified an autosomal recessive c.1048C > t;(p(Arg350*)) pathogenic mutation of exon 8 of the BSCL2 gene, which was present in a homozygous state in both patients. Conclusions Our paper contributes to further delineate a complex phenotype associated with BSCL2 mutation, underlining how seipin has a central and partially still unknown role that goes beyond adipose tissue metabolism, with a prominent involvement in central nervous system pathology.